Funding
Who raised, when, and from whom? Explore announced rounds, including emerging Indian companies, and company-reported SEC notices. Each amount keeps its original source and date.
363 filings · Form D notices of private raises, 2024-01-02 to 2026-03-31
Pelthos Therapeutics Inc.Pharmaceuticals
Durham, North Carolina · founded 2021 · Options, Convertible, Senior secured convertible notes, which are convertible in · 8 investors · Matthew Pauls, Peter Greenleaf
VST BIO CorpPharmaceuticals
San Diego, California · Equity · 1 investors · David Cheresh, Chris Somerville
ZETAGEN THERAPEUTICS, INC.Pharmaceuticals
Syracuse, New York · Equity · 35 investors · Joe Loy, Richard Warburg
EPALEX CorpPharmaceuticals
Mountain View, California · Equity · 1 investors · Jon Saxe, Brendan Magrab
Shuttle Pharmaceuticals Holdings, Inc.Pharmaceuticals
Gaithersburg, Maryland · Options, Convertible · 1 investors · Christopher Cooper, Tyvin Rich
Osteal Therapeutics, Inc.Pharmaceuticals
Dallas, Texas · Equity · 10 investors · Martin Sands, Judson Cooper
Medsyn Biopharma LLCPharmaceuticals
Northville, Michigan · Equity · 16 investors · Martin Matthew, Brian Wood
Tango Therapeutics, Inc.Pharmaceuticals
Boston, Massachusetts · Equity · 1 investors · John Ketchum, Barbara Weber
Enfuego Therapeutics, Inc.Pharmaceuticals
Pittsboro, North Carolina · founded 2021 · Convertible · 12 investors · Joe McMahon, Chad Pecot
Alto Neuroscience, Inc.Pharmaceuticals
Mountain View, California · Equity, Options, Convertible · 7 investors · Adam Savitz, Amit Etkin
Quoin Pharmaceuticals, Ltd.Pharmaceuticals
Ashburn, Virginia · Equity, Options · 27 investors · Natalie Leong, Michael Myers
Triton Therapeutics, Inc.Pharmaceuticals
Stamford, Connecticut · founded 2025 · Equity · 4 investors · Annie Mitsak, Timothy Shannon
Corner Therapeutics, Inc.Pharmaceuticals
Watertown, Massachusetts · Debt, Options, Convertible · 4 investors · Alan Ezekowitz, Nick Seaver
Belhaven Biopharma Inc.Pharmaceuticals
Chapel Hill, North Carolina · founded 2020 · Equity, Convertible · 222 investors · Wes Wheeler, David Neal
Jaguar Health, Inc.Pharmaceuticals
San Francisco, California · Equity, Options · 1 investors · Jonathan Siegel, Steven King
PharmassetX Inc.Pharmaceuticals
Louisville, Kentucky · founded 2024 · Simple Agreement for Future Equity (SAFE) · 1 investors · Gerald Dryden, Terry Minton
Alto Labs LLCPharmaceuticals
Los Angeles, California · founded 2023 · SAFE · 2 investors · Adam Solomon, Matthew Makabeh
Apnimed, Inc.Pharmaceuticals
Cambridge, Massachusetts · Debt · 7 investors · Kevin Lind, Barry Wohl
Volastra Therapeutics, Inc.Pharmaceuticals
New York, New York · Equity · 11 investors · Sandra Peterson, Robert Mittendorff
Balanced Pharma IncPharmaceuticals
Cornelius, North Carolina · founded 2020 · Equity · 1 investors · Mark Sebree, John Keadle
Balanced Pharma IncPharmaceuticals
Cornelius, North Carolina · founded 2020 · Equity · 1 investors · Mark Sebree, John Keadle
Jaguar Health, Inc.Pharmaceuticals
San Francisco, California · Equity · 15 investors · Lisa Conte, Steven King
AlphaTON Capital CorpPharmaceuticals
Road Town, Tortola, Virgin Islands, British · Equity, Options, Convertible · 15 investors · Steven Mintz, Brittany Kaiser
ResBiotic Nutrition, Inc.Pharmaceuticals
Birmingham, Alabama · founded 2021 · Equity · 1 investors · Micheal Bush, Braxton Goodrich
TALPHERA, INC.Pharmaceuticals
San Mateo, California · Equity, Options, Convertible · 13 investors · Adrian Adams, Shakil Aslam
Psy Therapeutics, Inc.Pharmaceuticals
Boston, Massachusetts · Debt, Options, Convertible · 23 investors · David Barlow, Paul Murphy
Psy Therapeutics, Inc.Pharmaceuticals
Boston, Massachusetts · Debt, Options, Convertible · 23 investors · David Barlow, Paul Murphy
Enlaza Therapeutics, Inc.Pharmaceuticals
La Jolla, California · founded 2020 · Equity · 1 investors · Marcos Milla, Stephen Squinto
Reunion Neuroscience, Inc.Pharmaceuticals
Morristown, New Jersey · founded 2023 · Equity · 9 investors · Gregory Mayes, Michael Ehlers
OWP PHARMACEUTICALS, INC.Pharmaceuticals
Lisle, Illinois · Equity · 19 investors · Troy Hammond, Steve Bourne